|
US5578550A
(en)
|
1993-10-08 |
1996-11-26 |
American Cyanamid Company |
Herbicidal oxadiazole carbonamide compounds
|
|
JP3402153B2
(ja)
|
1997-10-01 |
2003-04-28 |
凸版印刷株式会社 |
耐水性および剛性に優れた含浸紙
|
|
US7214487B2
(en)
|
1998-06-26 |
2007-05-08 |
Sunesis Pharmaceuticals, Inc. |
Methods for identifying compounds that modulate enzymatic activities by employing covalently bonded target-extender complexes with ligand candidates
|
|
US6998233B2
(en)
|
1998-06-26 |
2006-02-14 |
Sunesis Pharmaceuticals, Inc. |
Methods for ligand discovery
|
|
ATE420366T1
(de)
|
2000-11-21 |
2009-01-15 |
Sunesis Pharmaceuticals Inc |
ERWEITERTER ßTETHERINGß ANSATZ ZUM SCHNELLEN AUFFINDEN VON LIGANDEN
|
|
US20080220441A1
(en)
|
2001-05-16 |
2008-09-11 |
Birnbaum Eva R |
Advanced drug development and manufacturing
|
|
US9157875B2
(en)
|
2001-05-16 |
2015-10-13 |
Benjamin P. Warner |
Drug development and manufacturing
|
|
CN101252991B
(zh)
|
2005-06-28 |
2012-10-03 |
住友化学株式会社 |
过氧化物分解催化剂
|
|
EP2511844B1
(en)
|
2006-10-10 |
2015-08-12 |
XRpro Sciences, Inc. |
X-ray microscope
|
|
WO2010072228A1
(en)
|
2008-12-22 |
2010-07-01 |
Xigen S.A. |
Novel transporter constructs and transporter cargo conjugate molecules
|
|
AR078793A1
(es)
|
2009-10-27 |
2011-12-07 |
Orion Corp |
Derivados de carboxamidas no esteroidales y acil hidrazona moduladores de receptores androgenicos de tejido selectivo (sarm), composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del cancer de prostata entre otros
|
|
AP2013006678A0
(en)
|
2010-08-16 |
2013-01-31 |
Boehringer Ingelheim Int |
Oxadiazole inhibitors of leukotriene production
|
|
WO2012027322A1
(en)
|
2010-08-26 |
2012-03-01 |
Boehringer Ingelheim International Gmbh |
Oxadiazole inhibitors of leukotriene production
|
|
TWI732259B
(zh)
|
2010-12-16 |
2021-07-01 |
美商建南德克公司 |
關於th2抑制作用之診斷及治療
|
|
TWI573792B
(zh)
|
2012-02-01 |
2017-03-11 |
歐陸斯迪公司 |
新穎治療劑
|
|
AR089853A1
(es)
|
2012-02-01 |
2014-09-24 |
Boehringer Ingelheim Int |
Inhibidores de oxadiazol de la produccion de leucotrienos para terapia de combinacion, composicion farmaceutica, uso
|
|
IN2012CH01573A
(es)
*
|
2012-04-20 |
2015-07-10 |
Advinus Therapeutics Ltd |
|
|
BR112015007513A2
(pt)
|
2012-10-26 |
2017-07-04 |
Hoffmann La Roche |
inibidores de tirosina quinase de bruton
|
|
JOP20200096A1
(ar)
|
2014-01-31 |
2017-06-16 |
Children’S Medical Center Corp |
جزيئات جسم مضاد لـ tim-3 واستخداماتها
|
|
LT3116909T
(lt)
|
2014-03-14 |
2020-02-10 |
Novartis Ag |
Antikūno molekulės prieš lag-3 ir jų panaudojimas
|
|
CA2946538A1
(en)
|
2014-04-04 |
2015-10-08 |
Del Mar Pharmaceuticals |
Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer
|
|
KR101635848B1
(ko)
|
2014-04-14 |
2016-07-05 |
한국세라믹기술원 |
탄소 비결합성 금속 나노입자가 함유된 잉크 기제 제조 방법 및 금속 나노입자가 분산된 잉크
|
|
KR101582834B1
(ko)
|
2014-04-14 |
2016-01-08 |
한국세라믹기술원 |
비수계 그래핀 코팅액 제조 방법
|
|
ES2907622T3
(es)
|
2014-10-06 |
2022-04-25 |
Merck Patent Gmbh |
Compuestos de heteroarilo como inhibidores de BTK y usos de estos
|
|
US9694084B2
(en)
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
GB201506871D0
(en)
|
2015-04-22 |
2015-06-03 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
KR20180029061A
(ko)
|
2015-07-13 |
2018-03-19 |
아비나스 인코포레이티드 |
단백질 분해의 알라닌계 조절인자 및 관련된 이용 방법
|
|
JP2019522633A
(ja)
|
2016-05-20 |
2019-08-15 |
ジェネンテック， インコーポレイテッド |
Ｐｒｏｔａｃ抗体コンジュゲート及び使用方法
|
|
GB201610147D0
(en)
|
2016-06-10 |
2016-07-27 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
JP6954994B2
(ja)
|
2016-08-16 |
2021-10-27 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
可逆性ｂｔｋ阻害剤としてのオキソ−イミダゾピリジン及びその使用
|
|
GB201614134D0
(en)
|
2016-08-18 |
2016-10-05 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
JP2019535746A
(ja)
|
2016-11-22 |
2019-12-12 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
ブルトン型チロシンキナーゼ（ｂｔｋ）阻害剤のｅ３リガーゼリガンドとのコンジュゲーションによるｂｔｋの分解および使用法
|
|
CA3042297A1
(en)
|
2016-11-22 |
2018-05-31 |
Dana-Farber Cancer Institute, Inc. |
Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use
|
|
UY37559A
(es)
|
2017-01-06 |
2018-05-31 |
Pharmacyclics Llc |
Pirazolo[3,4-b]piridina y pirrolo[2,3-b]piridina como inhibidores de la tirosina quinasa de bruton
|
|
AU2018213637B2
(en)
|
2017-01-24 |
2022-01-27 |
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. |
LSD1 inhibitor and preparation method and application thereof
|
|
JOP20190233A1
(ar)
|
2017-04-14 |
2019-10-02 |
Biogen Ma Inc |
نظائر بنزوازيبين بوصفها عوامل مثبطة لتيروزين كيناز بروتون
|
|
MX392531B
(es)
|
2017-06-29 |
2025-03-24 |
G1 Therapeutics Inc |
Formas morficas de g1t38 y metodos de preparacion de las mismas.
|
|
CN109422752B
(zh)
|
2017-09-03 |
2023-04-07 |
上海美志医药科技有限公司 |
一类具有抑制并降解布鲁顿酪氨酸蛋白激酶Btk活性的化合物
|
|
WO2019084030A1
(en)
|
2017-10-24 |
2019-05-02 |
Genentech, Inc. |
(4-HYDROXYPYRROLIDIN-2-YL) -HYDROXAMATE COMPOUNDS AND METHODS OF USE
|
|
WO2019084026A1
(en)
|
2017-10-24 |
2019-05-02 |
Genentech, Inc. |
(4-HYDROXYPYRROLIDIN-2-YL) -HETEROCYCLIC COMPOUNDS AND METHODS OF USE
|
|
WO2019118851A1
(en)
|
2017-12-14 |
2019-06-20 |
Dana-Farber Cancer Institute, Inc. |
Small molecule degraders that recruit dcaft15
|
|
WO2019148150A1
(en)
|
2018-01-29 |
2019-08-01 |
Dana-Farber Cancer Institute, Inc. |
Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use
|
|
CA3090275A1
(en)
|
2018-02-14 |
2019-08-22 |
Dana-Farber Cancer Institute, Inc. |
Irak degraders and uses thereof
|
|
MX2020008559A
(es)
|
2018-02-15 |
2021-01-08 |
Nuvation Bio Inc |
Compuestos heterocíclicos como inhibidores de la quinasa.
|
|
US11028088B2
(en)
|
2018-03-10 |
2021-06-08 |
Yale University |
Modulators of BTK proteolysis and methods of use
|
|
US20200121684A1
(en)
|
2018-03-10 |
2020-04-23 |
Yale University |
Modulators of btk proteolysis and methods of use
|
|
WO2019183523A1
(en)
|
2018-03-23 |
2019-09-26 |
Genentech, Inc. |
Hetero-bifunctional degrader compounds and their use as modulators of targeted ubiquination (vhl)
|
|
US11541056B2
(en)
|
2018-03-26 |
2023-01-03 |
Novartis Ag |
3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide derivatives
|
|
US11613543B2
(en)
*
|
2018-03-26 |
2023-03-28 |
Novartis Ag |
Substituted pyrrolo[2,3-d]pyrimidines as Bruton's Tyrosine Kinase inhibitors
|
|
CN108379591B
(zh)
|
2018-04-03 |
2022-03-29 |
深圳大学 |
免疫激动剂靶向化合物的合成及其应用
|
|
EP3793994B1
(en)
|
2018-05-14 |
2023-08-23 |
Biogen MA Inc. |
Inhibiting agents for bruton's tyrosine kinase
|
|
CA3102996A1
(en)
|
2018-07-20 |
2020-01-23 |
Dana-Farber Cancer Institute, Inc. |
Degraders that target proteins via keap1
|
|
IL281073B2
(en)
|
2018-08-28 |
2025-05-01 |
Merck Patent Gmbh |
History of imidazopyridines and pharmaceutical preparations containing them
|
|
CN113412259B
(zh)
|
2018-10-15 |
2024-07-16 |
紐力克斯治疗公司 |
通过泛素蛋白酶体途径降解btk的双官能化合物
|
|
CA3119773A1
(en)
|
2018-11-30 |
2020-06-04 |
Kymera Therapeutics, Inc. |
Irak degraders and uses thereof
|
|
WO2020127369A1
(en)
|
2018-12-21 |
2020-06-25 |
Ose Immunotherapeutics |
Bifunctional molecule directed against human pd-1
|
|
JP7675012B2
(ja)
|
2018-12-21 |
2025-05-12 |
オーエスイー・イミュノセラピューティクス |
二機能性抗ｐｄ－１／ｓｉｒｐａ分子
|
|
CN113614109A
(zh)
|
2018-12-21 |
2021-11-05 |
Ose免疫疗法公司 |
双功能抗pd-1/il-7分子
|
|
US20220143195A1
(en)
|
2019-02-13 |
2022-05-12 |
Nurix Therapeutics, Inc. |
Bifunctional compounds for degrading btk via ubiquitin proteosome pathway
|
|
WO2020165374A1
(en)
|
2019-02-14 |
2020-08-20 |
Ose Immunotherapeutics |
Bifunctional molecule comprising il-15ra
|
|
CN113727973B
(zh)
|
2019-02-15 |
2025-08-29 |
百时美施贵宝公司 |
可用作类法尼醇x受体调节剂的取代酰胺化合物
|
|
WO2020206035A1
(en)
|
2019-04-01 |
2020-10-08 |
G1 Therapeutics, Inc. |
Treatment of cdk4/6 inhibitor resistant neoplastic disorders
|
|
WO2020232330A1
(en)
|
2019-05-15 |
2020-11-19 |
Biogen Ma Inc. |
Inhibiting agents for bruton's tyrosine kinase
|
|
WO2020252397A1
(en)
|
2019-06-12 |
2020-12-17 |
Baylor College Of Medicine |
Small molecule proteolysis-targeting chimeras and methods of use thereof
|
|
AU2020301399B2
(en)
|
2019-06-24 |
2025-12-18 |
Dana-Farber Cancer Institute, Inc. |
HCK degraders and uses thereof
|
|
CN114174299B
(zh)
*
|
2019-07-26 |
2024-10-25 |
百济神州有限公司 |
通过btk抑制剂与e3连接酶配体缀合对布鲁顿氏酪氨酸激酶(btk)的降解以及使用方法
|
|
WO2021053495A1
(en)
*
|
2019-09-16 |
2021-03-25 |
Novartis Ag |
Bifunctional degraders and their methods of use
|
|
EP4051680B1
(en)
|
2019-10-30 |
2025-09-03 |
Biogen MA Inc. |
Condensed bi-heterocycles as inhibiting agents for bruton's tyrosine kinase
|
|
WO2021133894A1
(en)
|
2019-12-23 |
2021-07-01 |
Biogen Ma Inc. |
Btk inhibitors
|
|
US20230322761A1
(en)
|
2020-03-11 |
2023-10-12 |
Beigene, Ltd. |
Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use
|
|
CA3172498A1
(en)
|
2020-04-30 |
2021-11-04 |
Beigene, Ltd. |
Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use
|
|
TW202220972A
(zh)
|
2020-08-07 |
2022-06-01 |
美商百健Ｍａ公司 |
Ｂｔｋ抑制劑
|
|
CN116981675A
(zh)
|
2020-12-31 |
2023-10-31 |
百济神州有限公司 |
通过布鲁顿氏酪氨酸激酶（btk）抑制剂与e3连接酶配体的缀合降解btk和使用方法
|
|
KR20240017814A
(ko)
|
2021-05-05 |
2024-02-08 |
바이오젠 엠에이 인코포레이티드 |
브루톤 티로신 키나제의 분해를 표적으로 하는 화합물
|
|
WO2022268052A1
(en)
|
2021-06-21 |
2022-12-29 |
Beigene, Ltd. |
(r) -glutarimide crbn ligands and methods of use
|
|
WO2023110138A1
(en)
|
2021-12-17 |
2023-06-22 |
Zedira Gmbh |
Inhibitors of transglutaminases
|
|
HUE068724T2
(hu)
|
2021-06-30 |
2025-01-28 |
Zedira Gmbh |
Transzglutaminázok inhibitorai
|
|
DK4192813T3
(da)
|
2021-06-30 |
2024-09-02 |
Zedira Gmbh |
Inhibitorer af transglutaminaser
|
|
PL4192812T3
(pl)
|
2021-06-30 |
2025-02-03 |
Zedira Gmbh |
Inhibitory transglutaminaz
|
|
CA3235512A1
(en)
|
2021-10-22 |
2023-04-27 |
Xiaobao Yang |
Crbn e3 ligase ligand compound, protein degrader developed based thereon and their applications
|
|
EP4429770A1
(en)
|
2021-11-10 |
2024-09-18 |
Biogen MA Inc. |
Btk inhibitors
|
|
AU2022405474A1
(en)
|
2021-12-08 |
2024-07-18 |
Gluetacs Therapeutics (Shanghai) Co., Ltd. |
E3 ubiquitin ligase ligand compound, protein degrader developed based thereon and their applications
|
|
CN118414336A
(zh)
|
2021-12-30 |
2024-07-30 |
百济神州有限公司 |
通过使布鲁顿酪氨酸激酶(btk)抑制剂与e3连接酶配体缀合来降解btk及使用方法
|
|
JP2025501082A
(ja)
|
2021-12-30 |
2025-01-17 |
ベイジーン スウィッツァーランド ゲーエムベーハー |
ブルトン型チロシンキナーゼ（ｂｔｋ）阻害剤をｅ３リガーゼリガンドにコンジュゲートすることによるｂｔｋの分解及び使用方法
|